Whitehawk Therapeutics, Inc. (WHWK) stock
WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.12−0.01 (-0.32%)
Close on Nov 19, 2026Market cap $177.87MP/E –Yield –
Whitehawk Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Whitehawk Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $0, down 100.0% year over year. For fiscal 2025 it was $7.15M, down 72.5% from the year before. The highest annual figure on record is $25.98M in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.15M | -72.5% |
| FY2024 | Dec 31, 2024 | $25.98M | +6.7% |
| FY2023 | Dec 31, 2023 | $24.35M | +60.1% |
| FY2022 | Dec 31, 2022 | $15.22M | +8.7% |
| FY2021 | Dec 31, 2021 | $14.00M | 0.0% |
| FY2020 | Dec 31, 2020 | $14.00M | – |
| FY2019 | Dec 31, 2019 | $0 | -100.0% |
| FY2018 | Dec 31, 2018 | $20.16M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | – |
| Q1 FY2026 | Mar 31, 2026 | $0 | -100.0% |
| Q4 FY2025 | Dec 31, 2025 | $0 | -100.0% |
| Q3 FY2025 | Sep 30, 2025 | $0 | -100.0% |
| Q2 FY2025 | Jun 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $7.15M | +33.5% |
| Q4 FY2024 | Dec 31, 2024 | $7.24M | +14.4% |
| Q3 FY2024 | Sep 30, 2024 | $7.21M | +21.0% |
| Q2 FY2024 | Jun 30, 2024 | $6.18M | -0.4% |
| Q1 FY2024 | Mar 31, 2024 | $5.35M | -8.8% |
| Q4 FY2023 | Dec 31, 2023 | $6.33M | +21.0% |
| Q3 FY2023 | Sep 30, 2023 | $5.96M | +40.4% |
| Q2 FY2023 | Jun 30, 2023 | $6.20M | +80.4% |
| Q1 FY2023 | Mar 31, 2023 | $5.87M | +154.3% |
| Q4 FY2022 | Dec 31, 2022 | $5.23M | -62.3% |
| Q3 FY2022 | Sep 30, 2022 | $4.25M | – |
| Q2 FY2022 | Jun 30, 2022 | $3.44M | – |
| Q1 FY2022 | Mar 31, 2022 | $2.31M | +1822.5% |
| Q4 FY2021 | Dec 31, 2021 | $13.88M | +2.3% |
| Q3 FY2021 | Sep 30, 2021 | $0 | -100.0% |
| Q2 FY2021 | Jun 30, 2021 | $0 | -100.0% |
| Q1 FY2021 | Mar 31, 2021 | $120.00K | +5497.0% |
| Q4 FY2020 | Dec 31, 2020 | $13.57M | -27.9% |
| Q3 FY2020 | Sep 30, 2020 | $231.00K | -82.7% |
| Q2 FY2020 | Jun 30, 2020 | $15.00M | – |
| Q4 FY2018 | Dec 31, 2018 | $2.14K | – |
| Q3 FY2018 | Sep 30, 2018 | $18.82M | – |
| Q2 FY2018 | Jun 30, 2018 | $1.33M | – |
See a number that looks wrong?